Total Funding
65
72
Total FundingSeed raised
Growth Score
0 pts
Heat Score
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
54784
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer.
- Bernard A. Fox: Co-Founder / President / CEO
- Bernard A. Fox: COO
About the Company
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer.
Founded in Portland, OR in 2005 as a spinout of the Robert W. Franz Cancer Research Center within the Earle A. Chiles Research Institute, at Providence Portland Medical Center, UbiVac continues to build upon the
groundbreaking research being developed in the region.
